Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer

Table 3 Multivariant analysis of effects on overall survival stratified by residual disease after primary surgery.

Variable	Harzard	95%CI	P value
Age >60	1.26	1.02–1.57	0.03
FIGO stage IV	4.84	2.73–8.57	<0.01
Initial paclitaxel*	0.80	0.71–0.90	<0.01
IP chemotherapy	0.71	0.56–0.90	<0.01

Abbreviation: IP, intraperitoneal; 95%CI, 95% confidential interval; FIGO, International Federation of Gynecology and Obstetrics.
* Paclitaxel as front-line chemotherapy.

ISSN: 1477-7819